 |
|
Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury
Jia Liu, Ranyi Luo, Yinhao Zhang, Xiaojiaoyang Li
Clin Mol Hepatol. 2024;30(4):585-619. Published online 2024 Jul 1 DOI: https://doi.org/10.3350/cmh.2024.0222
|
|
Citations to this article as recorded by
 Artesunate: A potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma
Xinyue Liu, Yilin Cai, Yuanhao Zhang, Hetian Zhang, Sisi Tian, Yuxia Gong, Qinmei Song, Xiaotong Chen, Xiao Ma, Yueqiang Wen, Yu Chen, Jinhao Zeng
Pharmacological Research.2024; 210: 107526. CrossRef
|